第一个关于肝脏脑病变的治疗和预防的拉丁美洲共识
Fátima Higuera-de-la-Tijera1, Mario Reis Alvares-da-Silva2, Graciela Elia Castro-Narro3
1Departamento de Gastroenterología y Hepatología, Hospital General de México "Dr. Eduardo Liceaga", Ciudad de México, México.
Annals of hepatology
|October 24, 2025
概括
这一共识为拉丁美洲的肝脑病变 (HE) 管理提供了最新的指导方针. 它强调早期诊断和有效治疗,以改善患者的治疗结果和降低死亡率.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 胃肠病学 胃肠病学
- 临床实践指南 临床实践指南
背景情况:
- 肝脑病变 (HE) 是肝硬化的一种严重并发症,死亡率高.
- 在拉丁美洲,高等教育的管理有很大的差异.
- 需要标准化指导方针来改善高等教育成果.
研究的目的:
- 为高等教育管理制定特定区域的建议.
- 评估当前对高等教育的治疗策略.
- 为了在拉丁美洲标准化HE治疗方法.
主要方法:
- 这是一个共识过程,涉及来自9个拉丁美洲国家的15名专家.
- 在9个阶段使用名义组技术.
- 包括虚拟协作,投票和面对面的会议.
主要成果:
- 开发了23个基于证据的建议,用于HE治疗.
- 建议涵盖了最小的,公开的和经常性的HE.
- 这些指导方针涉及预防和管理策略.
结论:
- 该共识为高等教育提供了最新的,基于证据的指南.
- 旨在优化临床结果和患者的生活质量.
- 旨在减少与高等卫生相关的发病率,死亡率和再入院.
关键词:
肝硬化是肝硬化的一种疾病.达成共识 达成共识肝脏脑病变 肝脏脑病变是一种肝脏脑病变.最小的肝脏脑病变 - 肝脏脑病变.严重的肝脏脑病变 (Overt hepatic encephalopathy) 是一种严重的肝脏脑病变.更多相关视频
相关概念视频
Esophageal Varices-II: Clinical Features and Management
366
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
366
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
180
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
180
Chronic Pancreatitis II: Collaborative Care
311
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
311
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
249
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
249
Acute Pancreatitis II: Clinical Manifestations and Management
741
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
741
Alzheimer's Disease: Treatment
811
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
811


